- Investment Overview
COMPANY HIGHLIGHTS
> Robust product pipelines addressing multiple large market opportunities
> Two products currently in clinical trials
> Highly experienced executive and scientific team
> GMP-certified facilities in the PRC designed to international, U.S. FDA standards, and Chinese regulatory bodies’ standards
> The first cellular medicine company in China accredited with IS0 (International Standards Organization) 9001:2008 certification by internationally recognized quality management system SGS
Our strategy is to commercialize both home grown and partnered cellular medicine technologies in a safe and efficient manner, and achieve a leading position in the China specialty pharmaceutical market for cell therapeutics. Our near term objective is to pursue successful clinical trials in China for our KOA application. By applying U.S. Standard Operating Procedures (SOPs) and protocols and following authorized treatment plans in China we are differentiated with a first mover’s advantage and a fortified barrier to entry from competitors.
We believe that few competitors in China are as well-equipped as we are in the clinical trial development, diversified U.S. FDA protocol compliant manufacturing facilities, regulatory compliance and policy making participation, as well as a long-term presence in the U.S. with U.S.-based management and investor base.
We intend to continue our business development effort by adding other proven domestic and international biotechnology partners to monetize the China health care market.
- SEC Filings
FORM FILER DATE 
CELLULAR BIOMEDICINE GROUP, INC.(KLEIN NORMAN PAUL II)
06/06/13 (12/31/12)
CELLULAR BIOMEDICINE GROUP, INC.
05/20/13 (03/31/13)
CELLULAR BIOMEDICINE GROUP, INC.
05/16/13 (03/31/13)
CELLULAR BIOMEDICINE GROUP, INC.(WONG KEITH)
05/07/13
CELLULAR BIOMEDICINE GROUP, INC.(WONG KEITH)
05/07/13 (05/07/13)
CELLULAR BIOMEDICINE GROUP, INC.
05/02/13 (04/26/13)
CELLULAR BIOMEDICINE GROUP, INC.
04/24/13 (02/06/13)
CELLULAR BIOMEDICINE GROUP, INC.(LIU TONY)
04/17/13 (04/16/13)
CELLULAR BIOMEDICINE GROUP, INC.
04/08/13
CELLULAR BIOMEDICINE GROUP, INC.
04/04/13 (12/31/12)
CELLULAR BIOMEDICINE GROUP, INC.(DAI JIANPING)
04/02/13 (03/29/13)
CELLULAR BIOMEDICINE GROUP, INC.
04/02/13 (12/31/12)
CELLULAR BIOMEDICINE GROUP, INC.(DAI JIANPING)
03/25/13 (03/14/13)
CELLULAR BIOMEDICINE GROUP, INC.
03/20/13 (03/14/13)
CELLULAR BIOMEDICINE GROUP, INC.(LIU TONY)
03/13/13 (03/04/13)
CELLULAR BIOMEDICINE GROUP, INC.
03/08/13 (03/04/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP) (CAO WEI (WILLIAM))
02/22/13 (02/20/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP) (LIU WEN TAO (STEVE))
02/22/13 (02/20/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP) (CHAN ANDREW K)
02/22/13 (02/20/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
02/22/13
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP) (CAO WEI (WILLIAM))
02/19/13 (02/06/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP) (GLOBAL HEALTH INVESTMENT HOLDINGS LTD.)
02/19/13
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
02/19/13 (02/19/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP) (LIU WEN TAO (STEVE))
02/19/13 (02/06/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP) (GLOBAL HEALTH INVESTMENT HOLDINGS LTD.)
02/19/13 (02/06/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP) (CHAN ANDREW K)
02/19/13 (02/06/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
02/13/13 (02/13/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
02/12/13 (02/06/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
02/06/13
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
02/04/13 (01/31/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
02/01/13 (01/15/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
01/25/13 (01/18/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
01/22/13 (01/15/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
01/14/13 (12/17/12)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
12/20/12 (01/17/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
12/18/12 (12/17/12)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
12/07/12 (01/13/13)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
11/20/12 (11/13/12)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
11/09/12 (09/30/12)
CELLULAR BIOMEDICINE GROUP, INC.(EASTBRIDGE INVESTMENT GROUP CORP)
10/12/12 (10/11/12)
- Stock Info
Stock Info
Share Structure
Market Value $39,738,516 a/o June 6, 2013 Shares Outstanding 5,726,011 a/o May 13, 2013 Shareholders
Shareholders of Record 1,600 a/o Mar 30, 2012 Transfer Agents: Jersey Transfer & Trust Co
Security Notes: Capital Change=shs decreased by 1 for 100 split. Ex-date=01/31/2013
- Email Alerts
If you would like to receive electronic copies of Cellular Biomedicine Group's public announcements, please submit your email address below.
We will only use your email address to send you more information about Cellular Biomedicine Group. Your email address will not be shared with any third parties.
Translating Innovation into Regeneration
SEC Filings
Copyright @2013 ©CBMG. All Rights Reserved. Legal Notice
